Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2010 Jul–Sep;24(3):213–219. doi: 10.1097/WAD.0b013e3181d1b99b

Table 4. Odds ratios from co-twin control analyses.

CLINICAL COHORT REGISTER COHORT

AD VaD All dementias All dementias
MZ + DZ MZ MZ + DZ MZ MZ + DZ MZ MZ + DZ MZ
HRs 95% CI HRs 95% CI HRs 95% CI HRs 95% CI HRs 95% CI HRs 95% CI HRs 95% CI HRs 95% CI
CVD 1.22 (0.51-2.95) 1.33 (0.30-5.96) 3.33 (1.34-8.30) Non-est* 1.86 (1.11-3.13) 2.00 (0.75-5.33) 1.29 (0.98-1.72) 1.76 (1.03-3.01)
MI 1.75 (0.51-5.98) 2.00 (0.18-22.06) 8.00 (1.84-34.79) Non-est* 2.36 (1.17-4.78) 2.25 (0.69-7.31) 1.11 (0.79-1.57) 2.25 (1.14-4.44)

Odds ratios (OR) with 95% confidence interval (CI) by dementia subtype and zygosity groups.

*

Among identical twin pairs, no twin without CVD developed VaD which makes it impossible to estimate an OR. Abbreviations: AD, Alzheimer's disease; VaD, vascular dementia; MZ, monozygous twin pairs; DZ, dizygous twin pairs; CVD, cardiovascular disease; MI, myocardial infarction.